Weill Cornell Initiative for Maximizing Student Development
Weill Cornell Initiative for Maximizing Student Development
批准号:
10405468
负责人:
ETHEL CESARMAN
金额:
$51.8万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-01 至 2024-04-30
关键词:
AddressBiomedical ResearchCareer ChoiceCareer ExplorationCommunitiesCommunity Health EducationCommunity NetworksDevelopmentDevelopment PlansDoctor of PhilosophyEducational CurriculumEducational process of instructingEventFacultyFosteringFundingGoalsHealthcareIndividualInstitutionInterventionInterviewLeadershipLifeMeasuresMedicineMemorial Sloan-Kettering Cancer CenterMentorsMentorshipMinority-Serving InstitutionNew York CityOutcomePerformancePreparationQualifyingReadinessResearchResourcesSchoolsScienceSelf EfficacySliceStreamStudentsTrainingUnderrepresented MinorityUnderrepresented Populationsbiomedical scientistcareercareer developmentcourse developmentdesigndoctoral studentexternshipgraduate school preparationhealth care disparityhigher educationinnovationlaboratory curriculumleadership developmentmembernext generationprogramsracial and ethnicrecruitself-renewalskillssocialsymposiumtoolunderrepresented minority student
中文摘要
项目概要/摘要
威尔康奈尔大学研究生院(WCGS)-威尔康奈尔大学与
医学和纪念斯隆凯特琳癌症中心-是一个首屈一指的机构博士培训,
生物医学科学我们希望利用我们的培训能力(2.75亿美元的研究资金,340名研究生
学校教师和330多名博士生),以提高我们的吸引率,保留,和发展
代表性不足的少数民族(URM)博士生作为生物医学劳动力的领导者。为了实现这一
目标,我们提出了一个威尔康奈尔IMSD计划,其目标如下:(1)吸引一个准备充分的游泳池
URM学生通过与当地和少数民族服务机构的合作伙伴关系到WCGS;(2)建立一个强大的,
URM博士生和教师通过早期启动计划,多方面的自我更新社区
导师制和社交聚会;以及(3)为IMSD学者提供领导力培训,专业技能
和网络成为各种生物医学和科学相关职业的领导者。WCGS已准备好进行培训
下一代URM生物医学科学家,我们相信,通过威尔康奈尔IMSD,我们
可以培养出一批训练有素的博士生,这将使他们多样化,并为他们带来创新。
生物医学劳动力。
英文摘要
Project Summary/Abstract
The Weill Cornell Graduate School (WCGS)—an educational and training partnership between Weill Cornell
Medicine and Memorial Sloan Kettering Cancer Center—is a premier institution for PhD training in the
biomedical sciences. We look to leverage our training capacity ($275 million in research funding, 340 graduate
school faculty, and over 330 PhD students) to increase our rates of attracting, retaining, and developing
underrepresented minority (URM) doctoral students as leaders in the biomedical workforce. To accomplish this
goal, we propose a Weill Cornell IMSD program with the following aims: (1) Attract a pool of well-prepared
URM students to WCGS through partnerships with local and minority-serving institutions; (2) Build a robust,
self-renewing community of URM doctoral students and faculty through an early start program, multifaceted
mentorship, and social gatherings; and (3) Equip IMSD scholars with leadership training, professional skills
and networks to be leaders in a variety of biomedical and science-related careers. WCGS is primed for training
the next generation of URM biomedical scientists and we are confident that through the Weill Cornell IMSD, we
can develop a steady stream of well-trained PhD's that will both diversify and bring innovation to the
biomedical workforce.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)
-
批准号:10592130
-
项目类别:
-
资助金额:$44.89万
-
财政年份:2023
-
负责人:ETHEL CESARMAN
-
依托单位:
Next-Gen Oncopathology Program
-
批准号:10676213
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
Rapid Sample-to-Answer Diagnosis of Kaposi's Sarcoma Across Sub-Saharan Africa using KS-COMPLETE
-
批准号:10416778
-
项目类别:
-
资助金额:$65.74万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
Rapid Sample-to-Answer Diagnosis of Kaposi's Sarcoma Across Sub-Saharan Africa using KS-COMPLETE
-
批准号:10642906
-
项目类别:
-
资助金额:$61.26万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
B cell determinants of EBV latency
-
批准号:10541734
-
项目类别:
-
资助金额:$86.4万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
B cell determinants of EBV latency
-
批准号:10701826
-
项目类别:
-
资助金额:$82.78万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
-
批准号:10228431
-
项目类别:
-
资助金额:$120.03万
-
财政年份:2021
-
负责人:ETHEL CESARMAN
-
依托单位:
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
-
批准号:10616708
-
项目类别:
-
资助金额:$117.81万
-
财政年份:2021
-
负责人:ETHEL CESARMAN
-
依托单位:
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
-
批准号:10398963
-
项目类别:
-
资助金额:$117.86万
-
财政年份:2021
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10737765
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10397107
-
项目类别:
-
资助金额:$41.69万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10532587
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10617688
-
项目类别:
-
资助金额:$41.69万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10165675
-
项目类别:
-
资助金额:$41.69万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
Weill Cornell Initiative for Maximizing Student Development
-
批准号:9893726
-
项目类别:
-
资助金额:$51.8万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
Role of novel onco-histone mutations in B-cell malignancies
-
批准号:10671507
-
项目类别:
-
资助金额:$65.16万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
Role of novel onco-histone mutations in B-cell malignancies
-
批准号:10454959
-
项目类别:
-
资助金额:$65.16万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
Weill Cornell Initiative for Maximizing Student Development
-
批准号:10618368
-
项目类别:
-
资助金额:$51.8万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
The 22nd International Conference on Kaposi's sarcoma-associated herpesvirus and Related Agents
-
批准号:9763269
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
Targeting vFLIP for the treatment of KSHV-associated malignancies
-
批准号:8433482
-
项目类别:
-
资助金额:$32.96万
-
财政年份:2011
-
负责人:ETHEL CESARMAN
-
依托单位:
海外基金